4DX is a listed company. Its insiders report their share dealings to ASX. The last twelve months, up to 18 October 2026, brought 6 filings signed by 6 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Compared with its exchange (2,530 companies, median 3 filings), a count of 6 filings is above the norm.
Insider buying of 4DX has been absent for the past year. Filings reach the ASX feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public.
This summary is built from ASX disclosures alone and does not predict where the share price will go.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2025 · cache
6 of 6 declarations
4DX is a company listed on the XASX, specializing in the development of innovative technologies in the healthcare sector. It focuses on enhancing medical treatments through data-driven solutions.